SIMILAC 5HMO 1

Similac® 5HMO 1 (0-6 months) 850g

LEADING IMMUNOPROTECTION SCIENCE TO SUPPORT INNATE AND ADAPTIVE IMMUNITY2,3,6,11#

  • Suitable for infants and toddlers (0-6 months)

  • Dual immune blend is designed for a unique combination of 5 HMOs and NTs to provide benefits in baby's digestive health, immunity and brain development1-11; with inclusion of 3-FL, one of the most abundant HMOs in breast milk, which helps inhibit pathogen adhesion as well as supporting intestinal barrier and motility4,12,13

  • Clinically proven 2’- FL + NTs formula to support immunity1-3,14,15 which is associated with significantly fewer respiratory infections by 66%15, resisting pathogen invasion

  • No added sucrose, non-GMO*, no palm olein oil 

 

IMPORTED FROM IRELAND

Ingredients

Nonfat milk, lactose, VEGETABLE OILS (high oleic sunflower oil, soy oil, coconut oil), whey protein concentrate, oligosaccharide blend (2'-fucosyllactose, lacto-N-tetraose, 3-fucosyllactose, 6'-sialyllactose, 3'-sialyllactose), MINERALS (potassium citrate, calcium carbonate, acidity regulator (potassium hydroxide), magnesium chloride, sodium chloride, ferrous sulfate, zinc sulfate, copper sulfate, calcium chloride, tricalcium phosphate, manganese sulfate, potassium iodide, sodium selenate), whey protein hydrolysate, arachidonic acid (AA), VITAMINS (ascorbic acid, antioxidant (ascorbyl palmitate), d-alpha-tocopheryl acetate, niacinamide, calcium d-pantothenate, retinyl palmitate, thiamin HCI, pyridoxine HCI, riboflavin, folic acid, phylloquinone, d-biotin, cholecalciferol, cyanocobalamin), emulsifier (soy lecithin), docosahexaenoic acid (DHA), myo-inositol, choline bitartrate, NUCLEOTIDES (cytidine 5'-monophosphate, disodium guanosine 5'-monophosphate, disodium uridine 5'-monophosphate, adenosine 5'-monophosphate), choline chloride, taurine, L-tryptophan, antioxidant (mixed tocopherols), L-carnitine, CAROTENOIDS (lutein, β-carotene).

Contains milk and soy ingredients. Source of Protein - Cow's milk protein.

* Not from human milk

Nutrition Information

Nutrition Information
UnitPer 100gPer 100ml
 
UnitPer 100gPer 100ml
Energykcal51665Chloridemg28035
Proteing10.601.34Zincmg3.600.45
Total Fatg28.123.55Ironmg4.320.55
  Linoleic acidg5.800.73Coppermg0.320.04
  α-Linolenic acidg0.560.07Manganeseµg8010
  Arachidonic acid (AA)mg11214Iodineµg80.010.1
  Docosahexaenoic acid (DHA)mg547Seleniumµg7.81.0
Total Carbohydratesg56.187.10Vitamin Aµg RE45357
     Dietary fiberg1.980.25Vitamin D3µg7.400.93
          Oligosaccharide blend (5 HMOs*)mg1980250Vitamin Emg α-TE11.91.5
Carnitinemg6.20.8Vitamin Kµg42.35.3
Taurinemg23.22.9Vitamin Cmg64.08.1
Cholinemg112.014.1Thiaminemg0.540.07
Inositolmg99.212.5Riboflavinmg0.800.10
β-caroteneµg496Vitamin B6mg0.320.04
Luteinµg749Vitamin B12µg1.000.13
Calciummg30438Niacinmg4.000.51
Phosphorusmg18023Pantothenic acidmg3.040.38
Magnesiummg32.04.0Folic acidµg608
Sodiummg16721Biotinµg16.02.0
Potassiummg50063Nucleotide equivalentsmg45.65.8

RELATED PRODUCTS

RELATED CONTENT

Examining guidelines and new evidence in oncology nutrition

Examining guidelines and new evidence in oncology nutrition

Main Image


resource

Tagname
Article
title
Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/Examining-guidelines-and-new-evidence-in-oncology-nutrition-a-position-paper-on-gaps-and-opportunities-in-multimodal-approaches-to-improve-pati
Abstract

Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes. 

Publish Date:
Oct 2021

The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)

Main Image

resource

Tagname
ARTICLE
title
The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/hmb-article
Abstract

The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.

Publish Date:

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

Main Image

resource

Tagname
Article
title
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/The-Underappreciated-Role-of-Low-Muscle-Mass-in-the-Management-of-Malnutrition
Abstract

This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.

Publish Date:
Jan 2019

Footnotes:

#Helps strengthen the antibody response to Haemophilus influenzae type B vaccine and diphtheria vaccine, improve immune response and reduce incidence of diarrhea.

▲HMOs: Human Milk Oligosaccharides (2'-FL, 3-FL, 3'-SL, 6'-SL, LNT; Stage 1 & 2: 250mg/100ml; Stage 3 & 4: 180mg/100ml), not from human milk.

△NTs: Nucleotides (RTF: 7.2mg/100ml; Stage 1 & 2: 5.8mg/100ml; Stage 3 & 4: 3mg/100ml). 

*Non-genetically modified organisms for Stage 1-4 powder. 

References:

  1. Similac HMO Product Information
  2. Goehring KC, et al. J Nutr. 2016;146(12):2559-2566. 
  3. Yau KI, et al. J Pediatr Gastroenterol Nutr. 2003;36(1):37-43. 
  4. Hill DR, et al. Nutrients. 2021;13(10):3364. 
  5. Walsh C, et al. J Funct Foods. 2020;72:104074. 
  6. Bode L. Glycobiology. 2012;22(9):1147-1162. 
  7. Buck RH, et al. Pediatr Res. 2004;56(6):891-900. 
  8. Weichert S, et al. Nutr Res. 2013;33(10):831-838. 
  9. Zehra S, et al. J Food Sci. 2018;83(2):499-508. 
  10. Uauy R, et al. J Nutr. 1994;124(8 Suppl):1436S-1441S. 
  11. Pickering LK, et al. Pediatrics. 1998;101(2):242-249. 
  12. Soyyılmaz B, et al. Nutrients. 2021;13(8):2737. 
  13. Li Z, et al. Crit Rev Food Sci Nutr. 2022;1-15. 
  14. Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649-658. 
  15. Reverri EJ, et al. Nutrients. 2018;10(10):1346. 

 

HKG.2025.58161.PND

Order ID: #12345
Order Date: 01/05/2024
Product Product Flavour Product Quantity
Loading...

SESSION TIMEOUT

Your session is about to expire in {min} minutes and you will be logged out. Do you wish to stay logged in?
UK-N/A-2400058 (V8) | October 2024

You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.

You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.

UK-N/A-2400058 (V8) | October 2024
bookmarkbookmarkedbookmark-hover
Click here to add this page to your bookmarks.

This page has been added to your bookmark. To access your bookmark list, Click this link.